|
|
|
|
 |
|
|
|
【NACI建議用使用Medicago新冠疫苗】不可作為加強針
(2022/3/11)
【明報專訊】國家免疫顧問委員會(NACI)今日建議市民可以接種以魁省為基地Medicago生產的新冠疫苗Covifenz。這款疫苗適合18至64歲人士接種。首劑和次劑的疫苗間隔，NACI建議是8周。
NACI表明，Covifenz疫苗，暫不能作為加強針使。
|
|
|
|
|
|
|
|
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
| |
| A D V E R T I S E M E N T |
|
| |
| |
| |
|
|
|
| |
|
|
|
| [] [] [] [] [] [] |
|
|
|
| MING PAO DAILY NEWS |
| A wholly owned subsidary of Ming Pao Enterprise Corporation Ltd. |
|
|
1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1
Tel.: (416) 321-0088 Fax: (416) 321-9663 Advertising Hotline Tel: (416) 673-8250
|
|
|
|
